Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Dow
McKinsey
Johnson and Johnson
Medtronic

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Givinostat

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Givinostat: Sponsors, patents, clinical trial progress

Givinostat is an investigational drug.

There have been 8 clinical trials for Givinostat. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2016.

The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Arthritis, Juvenile. The leading clinical trial sponsors are Italfarmaco, inVentiv Health Clinical, and Parexel.

There are seven US patents protecting this investigational drug and fifty-eight international patents.

Recent Clinical Trials for Givinostat
TitleSponsorPhase
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular DystrophyItalfarmacoPhase 2
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular DystrophyinVentiv Health ClinicalPhase 3
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular DystrophyItalfarmacoPhase 3

See all Givinostat clinical trials

Clinical Trial Summary for Givinostat

Top disease conditions for Givinostat
Top clinical trial sponsors for Givinostat

See all Givinostat clinical trials

US Patents for Givinostat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Givinostat   Start Trial Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester Italfarmaco SpA (Milano, IT)   Start Trial
Givinostat   Start Trial Method for treating Philadelphia-negative myeloproliferative syndromes Italfarmaco SpA (Milan, IT)   Start Trial
Givinostat   Start Trial Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester Chemi SPA (Cinisello Balsamo, IT)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Mallinckrodt
Merck
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.